RANK/RANKL: regulators of immune responses and bone physiology (Q37348448)

19 August 2017

1 reference

title

RANK/RANKL: regulators of immune responses and bone physiology (English)

1 reference

19 August 2017

1 reference

Josef M Penninger

2

0 references

author name string

Andreas Leibbrandt

series ordinal

1

1 reference

PubMed ID

19076348

19 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

Annals of the New York Academy of Sciences

19 August 2017

1 reference

19 August 2017

1143

1 reference

19 August 2017

123-150

1 reference

Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity

19 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1443.016

Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1443.016

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1443.016

Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1443.016

Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1443.016

IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1443.016

IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1443.016

Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1443.016

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0092-8674(91)90499-O

Identifiers

DOI

10.1196/ANNALS.1443.016

1 reference

19 August 2017

1 reference

PubMed ID

19076348